Decision Diagnostic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Perion Network (NASDAQ:PERI – Get Free Report) and Decision Diagnostics (OTCMKTS:DECN – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, dividends and profitability. Volatility & Risk Perion Network […]

Zscaler (NASDAQ:ZS – Free Report) and Decision Diagnostics (OTCMKTS:DECN – Free Report) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk. Risk & Volatility Zscaler has a beta of 0.85, […]

To print this article, all you need is to be registered or login on Mondaq.com. In December, the SEC filed a  complaint against Decision Diagnostics and its CEO, Keith Berman, for falsely claiming the company had developed a finger prick blood test that could instantaneously detect COVID-19.  As stated in its complaint, the SEC temporarily suspended trading of Decision Diagnostics' securities on April 23, 2020. Now, investors have brought suit as well.  Three institutional investors  claim the company – which was already in financial distress as a result of ...

Share this article Share this article NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Decision Diagnostics Corporation ("Decision Diagnostics" or the "Company") (OTCMKTS: DECN) and certain of its officers. The class action, filed in United States District Court for the Central District of California, and docketed under 21-cv-00418, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Decision Diagnostics securities between March 3, 2020 and December 17, 20...

Press release content from NewMediaWire. The AP news staff was not involved in its creation. DECISION DIAGNOSTICS CLASS ACTION REMINDER Faruqi & Faruqi LLPFebruary 28, 2021 GMT Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options NEW YORK, NY - ( NewMediaWire ) - February 28, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Decision Diagnostics Corp. (“Decision Diagnostics” or the “Company”...